CMS delays Maternal Opioid Misuse model start date to July 2021
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM) Model, due to COVID-19. Awardees now have until July 1, 2021 to screen and enroll beneficiaries in the MOM model, which seeks to address the sometimes-fragmented care of pregnant and postpartum Medicaid beneficiaries who have opioid-use disorders.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
Perinatal mental health disorders affect countless mothers during pregnancy and postpartum, yet access to comprehensive care remains a challenge. Hospitals are…
Blog
When I delivered my first baby in 2016, I did not understand how I would feel postpartum. Though I had many family members who had experienced birth and…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
The Department of Health and Human Services Health Resources and Services Administration is accepting applications until April 22 for its four-year Rural…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…